Wegovy® pill launches in the UAE as Novo Nordisk expands
Novo Nordisk launches Wegovy® pill in the United Arab Emirates todayWegovy® pill is indicated to reduce excess body…
Novo Nordisk to unveil data showing semaglutide tackles the liver disease crisis affecting about 1 in 3 people living with overweight and obesity worldwide
Trial liver safety data from the ‘ESSENCE’ trial confirm semaglutide’s favourable hepatic profile in patients with Metabolic Dysfunction-associated…
Generic medicine makers prepare to launch affordable options after Novo’s patent for Ozempic, Wegovy expires
Indian firms such as Ajanta Pharma, Dr Reddy’s Laboratories, Lupin, Mankind Pharma and Sun Pharmaceuticals are poised to…